A team of undergraduates from Imperial College, London last week won a competition aimed at encouraging entrepreneurship among young biotechnology researchers. Imperial's team produced a business plan for "InCap Technologies", an imaginary biotechnology company which aimed to produce an orally administered insulin product for the treatment of diabetes.
The team's success in the competition, which was launched by the Biotechnology and Biological Sciences Research Council, won them Pounds 1,000. A team from Reading University won a parallel competition for postgraduates with a business plan for the creation of "Inulinx", a firm specialising in developing genetically engineered crops to produce a fat substitute for food and non-food applications. The team won Pounds 500.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber? Login